|Bid||6,422.00 x 0|
|Ask||6,424.00 x 0|
|Day's Range||6,336.59 - 6,452.00|
|52 Week Range||5,130.00 - 8,191.30|
|Beta (5Y Monthly)||0.12|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 24, 2021|
|Forward Dividend & Yield||1.75 (2.77%)|
|Ex-Dividend Date||Aug 20, 2020|
|1y Target Est||7,085.56|
The company "Strongly believes that the claim is without merit and that it has strong grounds for defending against the claim should it be served," said Indivior, which was spun off from Reckitt in 2014. Indivior said that the claim has not been served yet. Last week, the British drugmaker disclosed that Reckitt had submitted a 1.07 billion pound claim earlier this month to the Commercial Court in London against Indivior relating to their demerger agreement.
While Reckitt Benckiser Group plc (LON:RB.) shareholders are probably generally happy, the stock hasn't had...
Reckitt Benckiser stock climbed on Tuesday, as surging demand for the Lysol maker’s hygiene and disinfectant products continued in the third quarter.